Answers are grounded in this paper and cite their sources.
Clinical Question: Is the use of procalcitonin for guiding antibiotic decisions in patients with acute upper and lower respiratory tract infections associated with improved clinical outcomes compared with usual care? Bottom Line: Among patients with varying types and severity of acute respiratory infection, using procalcitonin to guide decisions about antibiotics is associated with lower rates of antibiotic exposure, antibiotic-related adverse effects, and mortality.
No takes yet. Share an insight, caveat, or question.
Schüetz et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: